Furthermore, extracellular signal-regulated kinase (ERK1/2) pathway is involved in cell cycle progression and survival of non-small cell lung carcinoma cells resulting from CCR7 activation [39,40]. Here, CCR7 is linked to non-small cell lung carcinoma.